|
R-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1 H -1,4-benzodiazepine -3-yl]-3-(3-methylaminophenyl)urea |
|---|---|
| Trade Name | |
| Orphan Indication | Gastric carcinoids |
| USA Market Approval | USA |
| USA Designation Date | 2009-09-10 00:00:00 |
| Sponsor | Trio Medicines Ltd.;Pavillion View, Brighton BN1 1EY; |
